CELL DEATH AND DIFFERENTIATION
Scope & Guideline
Fostering Innovation in the Science of Cell Death and Differentiation
Introduction
Aims and Scopes
- Cell Death Mechanisms:
The journal explores the molecular pathways and mechanisms that regulate various forms of cell death, including programmed cell death (apoptosis), necroptosis, and autophagy, shedding light on their roles in health and disease. - Differentiation and Development:
Research articles focus on the processes of cell differentiation, including stem cell biology and developmental mechanisms, providing insights into how cells acquire specific functions and identities. - Cancer Biology:
The journal includes studies that investigate the relationship between cell death and cancer, exploring how tumor cells evade death, the role of cell death in tumor progression, and the potential for therapeutic targeting of cell death pathways. - Immunology and Inflammation:
Research on the interplay between cell death mechanisms and immune responses, particularly how cell death influences inflammation and immune regulation, is a core focus area. - Regenerative Medicine:
The journal emphasizes the implications of cell death and differentiation in regenerative medicine, including studies that explore therapeutic strategies to promote tissue regeneration and repair. - Metabolism and Cell Fate:
The interactions between metabolic processes and cell death are examined, highlighting how metabolic stress can influence cell survival and differentiation.
Trending and Emerging
- Ferroptosis Research:
Ferroptosis has emerged as a significant area of study, with increasing research focused on its role in cancer, neurodegeneration, and metabolic diseases. This interest is driven by the recognition of ferroptosis as a distinct form of regulated cell death that has therapeutic potential. - Interplay Between Metabolism and Cell Death:
There is a growing emphasis on understanding how cellular metabolism influences cell fate decisions, particularly in the context of cancer and metabolic disorders. This includes research on metabolic reprogramming and its effects on cell survival and death. - Cell Death in Immune Responses:
Research exploring the role of cell death mechanisms in modulating immune responses and inflammation is gaining traction, particularly in the context of autoimmune diseases and cancer immunotherapy. - Stem Cell Differentiation and Plasticity:
The study of stem cell differentiation processes and their regulation has become increasingly important, particularly regarding how cell death influences stem cell fate and tissue homeostasis. - Epigenetic Regulation of Cell Death:
Emerging research is focusing on the epigenetic modifications that regulate cell death pathways, highlighting the role of chromatin dynamics in controlling cell fate decisions. - Therapeutic Targeting of Cell Death Pathways:
There is a notable trend towards developing therapeutic strategies that target cell death pathways in cancer treatment, with an emphasis on exploiting vulnerabilities in tumor cells to induce cell death.
Declining or Waning
- Traditional Apoptosis Research:
Research focusing solely on classical apoptosis mechanisms has seen a decline as newer forms of cell death, such as ferroptosis and necroptosis, gain prominence. The field is moving towards more integrative approaches that encompass multiple cell death modalities. - Basic Mechanistic Studies:
There appears to be a waning interest in purely mechanistic studies of cell death pathways without a clear connection to disease models or therapeutic implications, as researchers increasingly seek to link findings to clinical relevance. - Single-Cell Analyses:
Although single-cell approaches have gained traction, traditional bulk analysis methods are being overshadowed by the demand for more nuanced, heterogeneity-focused studies that address cellular responses at a single-cell level. - In Vivo Models of Cell Death:
Research using simplistic in vivo models to study cell death mechanisms is declining in favor of more complex, human-relevant models that better mimic disease conditions, particularly in cancer and regenerative contexts.
Similar Journals
FEBS Journal
Exploring New Horizons in Molecular BiologyFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
Cell Death Discovery
Pioneering research at the forefront of cell biology.Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.
CELL PROLIFERATION
Exploring Innovations in Cellular and Molecular BiologyCELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.
CELL BIOLOGY INTERNATIONAL
Shaping the Future of Cell Biology and MedicineCELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.
DNA AND CELL BIOLOGY
Connecting Researchers to the Heart of BiologyDNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.
JOURNAL OF CELLULAR BIOCHEMISTRY
Exploring the Intricacies of Cellular ProcessesJournal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.
Cell Death & Disease
Bridging science and medicine for a healthier tomorrow.Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.
ACTA HISTOCHEMICA
Exploring the Cellular Landscape Through Histochemical InnovationACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.
Cell Journal
Advancing the Frontiers of Cell ScienceCell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.
Cells
Illuminating the World of Cells Through Groundbreaking ResearchCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.